• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

营养保健品及其在肿瘤血管生成中的作用。

Nutraceuticals and their role in tumor angiogenesis.

机构信息

Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, Bari, Italy.

Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, Bari, Italy.

出版信息

Exp Cell Res. 2021 Nov 15;408(2):112859. doi: 10.1016/j.yexcr.2021.112859. Epub 2021 Oct 9.

DOI:10.1016/j.yexcr.2021.112859
PMID:34637764
Abstract

Angiogenesis plays a pivotal role in cancer initiation, maintenance, and progression. Diet may inhibit, retard or reverse these processes affecting angiogenesis (angioprevention). Nutraceuticals, such as omega-3 fatty acids, amino acids, proteins, vitamins, minerals, fibers, and phenolic compounds, improve health benefits as they are a source of bioactive compounds that, among other effects, can regulate angiogenesis. The literature concerning the pro-angiogenic and/or anti-angiogenic nutraceuticals and the possible activated pathways in cancer and other non-neoplastic diseases by in vivo and in vitro experiments are reviewed.

摘要

血管生成在癌症的发生、维持和进展中起着关键作用。饮食可能会抑制、延缓或逆转这些影响血管生成的过程(血管预防)。营养保健品,如ω-3 脂肪酸、氨基酸、蛋白质、维生素、矿物质、纤维和酚类化合物,因其是生物活性化合物的来源而具有改善健康的益处,这些生物活性化合物除其他作用外,还可以调节血管生成。本文综述了体内和体外实验中关于促血管生成和/或抗血管生成的营养保健品,以及它们在癌症和其他非肿瘤性疾病中可能激活的途径。

相似文献

1
Nutraceuticals and their role in tumor angiogenesis.营养保健品及其在肿瘤血管生成中的作用。
Exp Cell Res. 2021 Nov 15;408(2):112859. doi: 10.1016/j.yexcr.2021.112859. Epub 2021 Oct 9.
2
Vaccination approach to anti-angiogenic treatment of cancer.癌症抗血管生成治疗的疫苗接种方法。
Biochim Biophys Acta. 2015 Apr;1855(2):155-71. doi: 10.1016/j.bbcan.2015.01.005. Epub 2015 Jan 30.
3
Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids.膳食脂肪酸和类二十烷酸对肿瘤血管生成的调控
Nutr Cancer. 2000;37(2):119-27. doi: 10.1207/S15327914NC372_1.
4
A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy.单克隆抗体癌症治疗的抗血管生成靶点综述
Int J Mol Sci. 2017 Aug 17;18(8):1786. doi: 10.3390/ijms18081786.
5
Polyphenol-based nutraceuticals for the control of angiogenesis: Analysis of the critical issues for human use.用于控制血管生成的基于多酚的营养保健品:对其在人体应用中的关键问题分析
Pharmacol Res. 2016 Sep;111:384-393. doi: 10.1016/j.phrs.2016.07.011. Epub 2016 Jul 8.
6
Cancer immunotherapy of targeting angiogenesis.靶向血管生成的癌症免疫疗法。
Cell Mol Immunol. 2004 Jun;1(3):161-6.
7
Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy.妇科恶性肿瘤中的血管生成及其抗血管生成治疗选择。
Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188446. doi: 10.1016/j.bbcan.2020.188446. Epub 2020 Oct 12.
8
Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.微环境在肿瘤生长以及对抗血管生成疗法的难治性/抗性中的作用。
Drug Resist Updat. 2008 Dec;11(6):219-30. doi: 10.1016/j.drup.2008.09.001. Epub 2008 Oct 23.
9
Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics.抗血管内皮生长因子的预测标志物和血管生成抑制剂作为免疫治疗药物的新作用。
Semin Cancer Biol. 2018 Oct;52(Pt 2):117-124. doi: 10.1016/j.semcancer.2017.12.002. Epub 2017 Dec 8.
10
Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis.源自草药的血管生成因子在调控控制肿瘤血管生成的分子途径中的作用。
Tumour Biol. 2016 Nov;37(11):14341-14354. doi: 10.1007/s13277-016-5330-5. Epub 2016 Sep 10.

引用本文的文献

1
Environmental Enrichment in Cancer as a Possible Tool to Combat Tumor Development: A Systematic Review.环境富集作为一种可能的抗肿瘤发展工具:系统综述。
Int J Mol Sci. 2023 Nov 20;24(22):16516. doi: 10.3390/ijms242216516.
2
The role of angiogenesis in melanoma: Clinical treatments and future expectations.血管生成在黑色素瘤中的作用:临床治疗与未来展望。
Front Pharmacol. 2022 Dec 15;13:1028647. doi: 10.3389/fphar.2022.1028647. eCollection 2022.